Register entry

Intersect ENT, Inc.

Data as of · How to read this entry

Registered sites
1
Active NDC listings
1
Live patents
6
Countries
1
Base
United States
Sites

Registered establishments

1
EstablishmentAddressRegistered forFEI / DUNS
Intersect ENT, Inc.1555 Adams Dr, Menlo Park, California (CA) 94025, United States (USA)Finished drug manufacture3008301917876715355
Exclusivity

Patents and exclusivities

6
PatentProductCoversExpiry
7544192SINUVAmometasone furoateuseNov 2026
8025635SINUVAmometasone furoateproductJun 2027
10357640SINUVAmometasone furoateuseOct 2031
8763222SINUVAmometasone furoateproductFeb 2032
10406332SINUVAmometasone furoateproductMar 2034
10232152SINUVAmometasone furoateproductNov 2034
Catalogue

Marketed products

1
BrandGeneric nameForm / routeNDC
Sinuvamometasone furoateimplant, intrasinal10599-003NDA
Compare

Comparable companies in United States

Enquiry

Common questions

Is Intersect ENT, Inc. FDA approved?
Intersect ENT, Inc. holds 1 FDA-registered establishment in the United States. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are Intersect ENT, Inc.'s drugs manufactured?
The FDA register lists Menlo Park, CA. Registered operations: finished drug manufacture.
What drugs does Intersect ENT, Inc. make?
1 product is listed under Intersect ENT, Inc. in the openFDA NDC Directory, most often as implant. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.